{
    "clinical_study": {
        "@rank": "72034", 
        "arm_group": [
            {
                "arm_group_label": "Adrenaline", 
                "arm_group_type": "Experimental", 
                "description": "Intraoperative low-dose adrenaline infusion"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo: Isotonic Saline"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of intraoperative administration of\n      low-dose adrenaline on intraoperative blood loss in patients undergoing hip surgery."
        }, 
        "brief_title": "The Effect of Administration of Low Dose Adrenaline During Surgery on Bleeding During Hip Surgery", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Intraoperative Blood Loss", 
        "condition_browse": {
            "mesh_term": "Hemorrhage"
        }, 
        "detailed_description": {
            "textblock": "Hip arthroplasty is associated with bleeding, anemia and the need for allogeneic\n      transfusion. Administration of low-dose adrenaline activates the coagulation system and may\n      decrease intraoperative and immediate postoperative bleeding. Thus, the aim of this study is\n      to evaluation whether intraoperative IV-administration of low-dose adrenaline reduces\n      bleeding in elective total hip arthroplasty."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years.\n\n          -  Scheduled for primary unilateral hip arthroplasty\n\n          -  Able to give consent\n\n        Exclusion Criteria:\n\n          -  Allergy towards adrenaline\n\n          -  Current treatment with: ADP receptor inhibitors or Vitamin K antagonists (within 5\n             days), Factor Xa inhibitors or Thrombin inhibitors (within 1 day), heparin (excluding\n             low molecular weight heparin for perioperative thromboprophylaxis).\n\n          -  Current treatment with tricyclic antidepressants\n\n          -  Use of MAO inhibitors (within previous 14 days) or COMT inhibitors (within 2 days).\n\n          -  Acute coronary syndrome / myocardial infarction within the previous 6 months.\n\n          -  not willing to accept blood transfusion\n\n          -  Participation in other clinical trial within previous 30 days\n\n          -  Women of childbearing age (without menopause for at least 12 months)\n\n          -  Glaucoma\n\n          -  Pheochromocytoma\n\n          -  Low serum K+ (< 3.0 mmol/L)\n\n          -  Thyrotoxicosis\n\n          -  Digoxin intoxication\n\n          -  Alcohol og drug abuse (investigators judgement)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708642", 
            "org_study_id": "RH-4074-OJ2", 
            "secondary_id": "2012-002889-12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Adrenaline", 
                "description": "Adrenaline infusion 0.05 microgram / kg / minute", 
                "intervention_name": "Adrenaline", 
                "intervention_type": "Drug", 
                "other_name": "Ephinephrine"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Intraoperative isotonic saline infusion as placebo for adrenaline.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epinephrine", 
                "Epinephryl borate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 17, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hellerup", 
                        "country": "Denmark", 
                        "zip": "2900"
                    }, 
                    "name": "Gentofte Hospital, Department of Anaesthesia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hvidovre", 
                        "country": "Denmark", 
                        "zip": "2650"
                    }, 
                    "name": "Hvidovre Hospital, Department of orthopaedic surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vejle", 
                        "country": "Denmark", 
                        "zip": "7100"
                    }, 
                    "name": "Vejle Sygehus, Department of orthopedic surgery"
                }
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Intraoperative Low Dose Adrenaline on Bleeding in Total Hip Arthroplasty - a Randomized Placebo-controlled Trial", 
        "other_outcome": {
            "description": "Side effects causing discontinuation the study drug.", 
            "measure": "Drug side effects", 
            "safety_issue": "Yes", 
            "time_frame": "During surgery (from start of procedure to last suture)"
        }, 
        "overall_official": [
            {
                "affiliation": "Rigshospitalet, Section for transfusion medicine", 
                "last_name": "P\u00e4r I Johanssion, M.D., DMsc.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Rigshospitalet, Section for Surgical Pathophysiology", 
                "last_name": "Oeivind Jans, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Medicines Agency", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Intraoperative blood loss as estimated from surgical drain and sponges.", 
            "measure": "Intraoperative blood loss", 
            "safety_issue": "No", 
            "time_frame": "End of surgery (last suture)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708642"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Oeivind Jans", 
            "investigator_title": "M.D, Research Fellow", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Calculated blood loss at 24 h after end of surgery.", 
            "measure": "Calculated blood loss", 
            "safety_issue": "No", 
            "time_frame": "24 hours after end of surgery."
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}